Charles Neivert

Stock Analyst at Piper Sandler

(1.49)
# 3,203
Out of 4,783 analysts
161
Total ratings
38.74%
Success rate
-10.9%
Average return

Stocks Rated by Charles Neivert

Westlake
Mar 26, 2025
Downgrades: Neutral
Price Target: $135$120
Current: $102.92
Upside: +16.60%
AdvanSix
Mar 18, 2025
Maintains: Overweight
Price Target: $39$35
Current: $23.06
Upside: +51.78%
Celanese
Feb 25, 2025
Maintains: Underweight
Price Target: $77$50
Current: $58.23
Upside: -14.13%
Ecolab
Feb 24, 2025
Maintains: Overweight
Price Target: $270$310
Current: $252.68
Upside: +22.68%
Albemarle
Feb 20, 2025
Maintains: Underweight
Price Target: $90$85
Current: $74.75
Upside: +13.71%
LyondellBasell Industries
Feb 13, 2025
Maintains: Neutral
Price Target: $95$84
Current: $70.95
Upside: +18.39%
Eastman Chemical Company
Feb 13, 2025
Maintains: Neutral
Price Target: $102$105
Current: $88.92
Upside: +18.08%
Dow Inc.
Feb 13, 2025
Maintains: Neutral
Price Target: $53$46
Current: $35.24
Upside: +30.53%
Olin Corporation
Feb 13, 2025
Downgrades: Neutral
Price Target: $41$33
Current: $25.25
Upside: +30.69%
Nutrien
Jan 27, 2025
Maintains: Overweight
Price Target: $58$63
Current: $50.90
Upside: +23.77%
Maintains: Neutral
Price Target: $30$33
Current: $27.48
Upside: +20.09%
Maintains: Overweight
Price Target: $105$115
Current: $77.98
Upside: +47.47%
Upgrades: Overweight
Price Target: $9$11
Current: $7.00
Upside: +57.14%
Maintains: Neutral
Price Target: $3.9$3.5
Current: $2.87
Upside: +21.95%
Downgrades: Neutral
Price Target: $200$170
Current: $129.79
Upside: +30.98%
Maintains: Overweight
Price Target: $68$71
Current: $35.99
Upside: +97.28%